A Phase 2, Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
A Phase 2, Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
This study will evaluate the safety, tolerability and efficacy of a single dose level of KB003 in subjects with inadequately controlled asthma.
Key Inclusion Criteria:
Key Exclusion Criteria:
Sugarland, Texas 77479, United States
Woolonggabba, Queensland 4102, Australia
Mrozy, Silesian Voivodeship 05-321, Poland
Piasta, 15-044, Poland